Osimertinib, Targeted drug, Third-generation irreversible EGFR-TKI, CNS metastasis activity, EGFRm NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation,
Sale!
Lucius
Replica: Targeted EGFRm NSCLC Treatment Osimertinib
Original price was: $625.00.$466.00Current price is: $466.00.
Osimertinib, Targeted drug, Third-generation irreversible EGFR-TKI, CNS metastasis activity, EGFRm NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation,
Reviews
There are no reviews yet.